)
Neuphoria Therapeutics (NEUP) investor relations material
Neuphoria Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for November 2, 2026, to be held virtually at 9:00 a.m. Eastern Time.
Proxy materials are available online, with options for electronic or paper delivery upon request.
Shareholders are encouraged to review all proxy materials and vote online or by requesting a paper ballot.
Voting matters and shareholder proposals
Election of one Class II director, Alan Fisher, for a three-year term expiring at the 2029 annual meeting.
Ratification of Wolf & Company P.C. as independent registered public accounting firm for fiscal year ending June 30, 2027.
Approval of potential adjournments of the annual meeting to solicit additional proxies if needed.
Board of directors and corporate governance
Board recommends voting FOR the director nominee and FOR both other proposals on the agenda.
- Annual Meeting to vote on director election, auditor ratification, and adjournment authorization.NEUP
Proxy filing - Annual meeting proxy materials are online for review and voting ahead of November 2, 2026.NEUP
Proxy filing - FY26 saw a sharp revenue drop, major restructuring, and a $5.4M goodwill impairment amid a pending merger.NEUP
Q4 2026 - All-share merger forms a Nasdaq-listed immunotherapy firm, backed by $89M in new financing.NEUP
Proxy filing - BNC210 advances in late-stage trials for anxiety and PTSD, with strong Merck-backed Alzheimer's program.NEUP
Corporate presentation - Key clinical and financial milestones achieved, with cash runway through Q2 2027.NEUP
Q4 2025 - Biotech seeks up to $100M for late-stage neuropsychiatric drug trials, leveraging ATM sales.NEUP
Registration filing - Biopharma seeks up to $100M for CNS drug trials, with $2M ATM, amid US redomicile and Nasdaq risks.NEUP
Registration filing - Net income surged on Merck milestone; BNC210 Phase 3 data expected Q3 2025, cash runway into 2027.NEUP
Q3 2025
Next Neuphoria Therapeutics earnings date
Next Neuphoria Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)